Cargando…
NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View
In the 2020 European Society of Cardiology guidelines on non-ST-segment elevation acute coronary syndromes (NSTE-ACS), the experts proposed to put an end to the equipoise of ticagrelor and prasugrel in addition to aspirin in patients with NSTE-ACS who proceed to percutaneous coronary intervention (P...
Autores principales: | Angoulvant, Denis, Sabouret, Pierre, Savage, Michael P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435520/ https://www.ncbi.nlm.nih.gov/pubmed/33674980 http://dx.doi.org/10.1007/s40256-021-00471-z |
Ejemplares similares
-
Clinical Implications of the 2013 ESH/ESC Hypertension Guidelines: Targets, Choice of Therapy, and Blood Pressure Monitoring
por: Kjeldsen, Sverre E., et al.
Publicado: (2014) -
Application of Layered Strain Technique in NSTE-ACS
por: Zhao, Nan, et al.
Publicado: (2022) -
Indications for an early invasive strategy in NSTE-ACS patients
por: Zwart, B., et al.
Publicado: (2019) -
2020 ESC Guidelines on acute coronary syndrome without ST-segment elevation: Recommendations and critical appraisal from the Dutch ACS and Interventional Cardiology working groups
por: Arslan, F., et al.
Publicado: (2021) -
Practical issues in clinical scenarios involving CKD patients requiring antithrombotic therapy in light of the 2017 ESC guideline recommendations
por: Covic, Adrian, et al.
Publicado: (2018)